Seeking Alpha
 

United Therapeutics Corporation (UTHR)

- NASDAQ
  • Fred Piard | Send Message 13 Apr

    $UTHR up 44% since I bought it in my Market Neutral Portfolio (december)
    Reply
      • TradeIt Mike | Send Message 10 Apr

        SHORT $UTHR 185.04
        Reply
          • Fred Piard | Send Message 8 Apr

            $UTHR up 38% since I bought it in December.
            Reply
              • TradeIt Mike | Send Message 26 Mar

                COVER $UTHR 168.15
                Reply
                  • Fred Piard | Send Message 16 Mar

                    $UTHR finally up 8% today, unrlz profit 36%
                    Reply
                      • Fred Piard | Send Message 16 Mar

                        $UTHR best holding in my Market Neutral Portfolio (and newsletter). +6.5% today, and more than 33% unrlz profit since late december.
                        Reply
                          • Jim Van Meerten | Send Message 20 Feb

                            $UTHR - 100% Barchart technical buy signals - 7 new hihgs and up 10.10% in the last month - Relative Strength Index 76.59%
                            Reply
                              • Jim Van Meerten | Send Message 20 Feb

                                United Therapeutics - Barchart's Chart Of The Day $UTHR http://seekingalpha.com/p/28joi
                                Reply
                                  • Eric Muathe | Send Message 21 Jan
                                    Reply
                                      • StockConsultant | Send Message 15 Jan

                                        $UTHR long top breakout above triple resistance area, http://bit.ly/1E5hmyk
                                        Reply
                                          Visit Seeking Alpha's
                                          UTHR vs. ETF Alternatives
                                          Company Description
                                          United Therapeutics Corp is a biotechnology company. The Company is engaged in thedevelopment and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.